Danaher Corporation has announced a significant move to strengthen its diagnostics portfolio by agreeing to acquire Masimo Corporation for approximately $9.9 billion in an all-cash deal, with shares priced at $180 each. This acquisition follows positive momentum for Masimo shares, which surged following reports of the acquisition discussions. The deal is seen as a strategic pivot for Danaher as it seeks to expand its capabilities in medical technology and diagnostics.